BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25053419)

  • 1. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
    Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
    J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
    Li M; Chiu JF; Gagne J; Fukagawa NK
    J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta.
    Escribano C; Delgado-Martín C; Rodríguez-Fernández JL
    J Immunol; 2009 Nov; 183(10):6282-95. PubMed ID: 19841191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
    Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
    J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
    Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
    PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors.
    Essaghir A; Dif N; Marbehant CY; Coffer PJ; Demoulin JB
    J Biol Chem; 2009 Apr; 284(16):10334-42. PubMed ID: 19244250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling.
    Terragni J; Nayak G; Banerjee S; Medrano JL; Graham JR; Brennan JF; Sepulveda S; Cooper GM
    J Biol Chem; 2011 Oct; 286(42):36215-27. PubMed ID: 21873430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.
    Akundi RS; Zhi L; Büeler H
    Neurobiol Dis; 2012 Jan; 45(1):469-78. PubMed ID: 21945539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
    Kuemmerle JF
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.
    Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H
    Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
    Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
    Fang CH; Li BG; James JH; King JK; Evenson AR; Warden GD; Hasselgren PO
    Endocrinology; 2005 Jul; 146(7):3141-9. PubMed ID: 15802492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt, and forkhead signaling.
    Poulsen RC; Carr AJ; Hulley PA
    Endocrinology; 2011 Feb; 152(2):503-14. PubMed ID: 21209015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
    Scalia P; Heart E; Comai L; Vigneri R; Sung CK
    J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ; Alfieri CM; Yutzey KE
    Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.
    Shukla S; Gupta S
    Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.